These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19320558)

  • 1. Exenatide improves hypertension in a rat model of the metabolic syndrome.
    Laugero KD; Stonehouse AH; Guss S; Landry J; Vu C; Parkes DG
    Metab Syndr Relat Disord; 2009 Aug; 7(4):327-34. PubMed ID: 19320558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
    Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA
    Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of AC3174, a peptide analog of exendin-4.
    Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM
    Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration.
    Gedulin BR; Smith PA; Jodka CM; Chen K; Bhavsar S; Nielsen LL; Parkes DG; Young AA
    Int J Pharm; 2008 May; 356(1-2):231-8. PubMed ID: 18291606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk reduction therapy for syndrome X: comparison of several treatments.
    Oron-Herman M; Sela BA; Rosenthal T
    Am J Hypertens; 2005 Mar; 18(3):372-8. PubMed ID: 15797656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.
    Timmers L; Henriques JP; de Kleijn DP; Devries JH; Kemperman H; Steendijk P; Verlaan CW; Kerver M; Piek JJ; Doevendans PA; Pasterkamp G; Hoefer IE
    J Am Coll Cardiol; 2009 Feb; 53(6):501-10. PubMed ID: 19195607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction induced by triglycerides is not restored by exenatide in rat conduit arteries ex vivo.
    Nathanson D; Erdogdu O; Pernow J; Zhang Q; Nyström T
    Regul Pept; 2009 Oct; 157(1-3):8-13. PubMed ID: 19595708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of exenatide on fat deposition and a metabolic profile in patients with metabolic syndrome.
    González-Ortiz M; Martínez-Abundis E; Robles-Cervantes JA; Ramos-Zavala MG
    Metab Syndr Relat Disord; 2011 Feb; 9(1):31-4. PubMed ID: 20874425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity.
    Ghanaat-Pour H; Sjöholm A
    Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 receptor agonists have a sustained stimulatory effect on corticosterone release after chronic treatment.
    Krass M; Volke A; Rünkorg K; Wegener G; Lund S; Abildgaard A; Vasar E; Volke V
    Acta Neuropsychiatr; 2015 Feb; 27(1):25-32. PubMed ID: 25469828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of controlled acute hyperglycemia in rats: Effects of insulin and glucagon-like peptide-1 analog.
    Saha JK; Xia J; Engle SK; Chen YF; Glaesner W; Jakubowski JA
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1159-64. PubMed ID: 16280413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of salt-induced hypertension by an analog of gamma-melanocyte-stimulating hormone in the rat.
    Ni XP; Humphreys MH
    Am J Hypertens; 2007 Aug; 20(8):862-5. PubMed ID: 17679034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension-independent microvascular rarefaction in the obese Zucker rat model of the metabolic syndrome.
    Frisbee JC
    Microcirculation; 2005; 12(5):383-92. PubMed ID: 16020387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological mechanisms for the increase in renal solute-free water clearance by a glucagon-like peptide-1 mimetic.
    Kutina AV; Marina AS; Shakhmatova EI; Natochin YV
    Clin Exp Pharmacol Physiol; 2013 Aug; 40(8):510-7. PubMed ID: 23692186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats.
    Liu Q; Adams L; Broyde A; Fernandez R; Baron AD; Parkes DG
    Cardiovasc Diabetol; 2010 Aug; 9():32. PubMed ID: 20678234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats.
    Solmaz V; Çınar BP; Yiğittürk G; Çavuşoğlu T; Taşkıran D; Erbaş O
    Eur J Pharmacol; 2015 Oct; 765():482-7. PubMed ID: 26386291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid prevents and partially reverses glucocorticoid-induced hypertension in the rat.
    Miao Y; Zhang Y; Lim PS; Kanjanapan Y; Mori TA; Croft KD; Earl J; Lee SY; McKenzie KU; Hu L; Whitworth JA
    Am J Hypertens; 2007 Mar; 20(3):304-10. PubMed ID: 17324744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid modulation of TRH and TRH-like peptide levels in rat brain and peripheral tissues by corticosterone.
    Pekary AE; Stevens SA; Sattin A
    Neurochem Int; 2006 Feb; 48(3):208-17. PubMed ID: 16293347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome.
    Bitto A; Altavilla D; Bonaiuto A; Polito F; Minutoli L; Di Stefano V; Giuliani D; Guarini S; Arcoraci V; Squadrito F
    J Endocrinol; 2009 Mar; 200(3):367-76. PubMed ID: 19066292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats.
    Fujita S; Ushio S; Ozawa N; Masuguchi K; Kawashiri T; Oishi R; Egashira N
    PLoS One; 2015; 10(11):e0141921. PubMed ID: 26536615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.